Obstructive sleep apnoea is associated with the development and progression of diabetic retinopathy, independent of conventional risk factors and novel biomarkers for diabetic retinopathy

British Journal of Ophthalmology

Volumn 96, Issue 12, 2012, Pages 1535-

  Rudrappa, Supreeth ^a   Warren, Graham ^b   Idris, Iskandar ^a,b  

^a SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; APNEA HYPOPNEA INDEX; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; EPWORTH SLEEPINESS SCALE; EXPLORATORY RESEARCH; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RETINA MACULOPATHY; RISK FACTOR; SCORING SYSTEM; SLEEP DISORDERED BREATHING;

BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84869864835     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301991     Document Type: Letter

References (6)

1. Tahrani AA, Ali A, Begum S, et al. Obstructive sleep apnoea and sight threatening retinopathy: a novel association in patients with Type 2 diabetes P158. Diabet Med 2011;28(S1), Abstracts of the Diabetes UK Annual Professional Conference.
2. Shiba T, Takahashi M, Hori Y, et al. Evaluation of the relationship between background factors and sleep-disordered breathing in patients with proliferative diabetic retinopathy. Jpn J Ophthalmol 2011;55:638-42.
3. Gustavsson C, Agardh E, Bengtsson B, et al. TNF-alpha is an independent serum marker for proliferative retinopathy in Type 1 diabetic patients. Diabetes Complication 2008;22:3009-16.
4. Myśliwiec M, Balcerska A, Zorena K, et al. The role of vascular endothelial growth factor, tumour necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Res Clin Pract 2008;79:141-6.
5. Jacqueminet S, Ben Abdesselam O, Chapman MJ, et al. Elevated circulating levels of matrix metalloproteinase-9 in Type 1 diabetic patients with and without retinopathy. Clin Chim Acta 2006;367:103-7.
6. Lee IG, Chae SL, Kim JC. Involvement of circulating endothelial progenitaor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye 2006;20:546-52.